Endowment / Foundation

Updated:

Camille and Henry Dreyfus Foundation

The Camille and Henry Dreyfus Foundation was established in 1946 by Camille Dreyfus, a Swiss chemist who co-founded the Celanese Corporation.

Camille and Henry Dreyfus Foundation logo

Camille and Henry Dreyfus Foundation

The Camille and Henry Dreyfus Foundation was established in 1946 by Camille Dreyfus, a Swiss chemist who co-founded the Celanese Corporation. After the death of his brother Henry in 1944, Camille dedicated a portion of his industrial fortune to create one of the few US foundations with a single-discipline mandate: to advance the chemical sciences. Governance remains tightly held within the Dreyfus family line through President H. Scott Walter and Secretary Mary Eileen Dowling Walter. The foundation’s capital, estimated at $104 million (Altss estimate), is deployed almost entirely through a programmatic grantmaking engine rather than direct venture or private equity investments. Its asset base includes publicly traded securities and corporate bonds, managed to sustain annual distributions for four signature programs. The Postdoctoral Program in Environmental Chemistry seeds early-stage academic labs. The Henry Dreyfus Teacher-Scholar Awards Program targets undergraduate-focused faculty. Its most visible asset is the Dreyfus Prize in the Chemical Sciences, a biennial $250,000 award that has recognized figures including MIT’s Robert Langer and Caltech’s Frances Arnold. The foundation also partners with the American Chemical Society (ACS) to administer national symposia and named lectureships. The foundation’s operational footprint is lean, run by Executive Director Scott Siegel out of a leased office at 405 Lexington Avenue in New York. The board blends family trustees—Henry C. Walter served as president from 2009 to 2020—with scientific advisors like Matthew V. Tirrell, dean of the University of Chicago’s Pritzker School of Molecular Engineering. While it does not operate adjacent investment vehicles, the foundation’s philanthropic capital is permanently wedded to its chartered mission: grantmaking in chemistry, not principal investment returns. In 2023, the foundation awarded a new round of Dreyfus Prize nominations, reinforcing its role as the discipline’s most concentrated private funder. Structurally, the Dreyfus Foundation sits in a rare class of asset owners: a single-mission science funder whose grantmaking produces measurable academic output—faculty hires, published research, and Nobel-caliber recognition—rather than portfolio exits. The prize committee draws from the ACS and the National Academy of Sciences, creating a sourcing network for talent discovery that looks more like fellowship curation than endowment management. That model, sustained across eight decades, has made the foundation’s financial underwriting the de facto subsidy for early-stage theoretical and environmental chemistry research in America.

General information

Firm type

Endowment / Foundation

Year founded

1946

Location

Region

North America

Country

United States

City

New York

Corporate office

405 Lexington Avenue, Suite 909, New York, NY 10174, United States

Principals

H. Scott Walter

President of the Board

Scott Siegel

Executive Director

Mary Eileen Dowling Walter

Treasurer and Secretary

Milan Mrksich

Chair of the Scientific Affairs Committee and Board Member

Matthew V. Tirrell

Senior Scientific Advisor and Director

Paul Woitach

Vice President of the Foundation

Sector focus

Healthcare ServicesIndustrial TechEducation

Frequently asked questions

Who runs investment decisions at the Camille and Henry Dreyfus Foundation?

The foundation does not invest directly in companies or operate as a venture firm. Asset management oversight rests with the Board, currently led by President H. Scott Walter, with day-to-day financial management administered by Executive Director Scott Siegel. The portfolio consists primarily of publicly traded securities and corporate bonds, structured to fund annual grantmaking rather than generate principal growth.

How does the foundation source its awardees and grant recipients?

The foundation’s scientific leadership—including Senior Scientific Advisor Matthew V. Tirrell and the Scientific Affairs Committee chaired by Milan Mrksich—works in collaboration with the American Chemical Society and the National Academy of Sciences to identify candidates. Selection emphasizes early-career researchers and undergraduate-focused faculty, creating a structured talent pipeline rather than accepting unsolicited proposals for its major prizes.

Does the Dreyfus Foundation take equity positions in biotech or materials science startups?

No. Despite its alignment with the chemical sciences, the foundation is not an early-stage investor in commercial ventures. Its capital is used exclusively for charitable grants, awards, and educational programs. There is no record of the foundation making direct equity investments, co-investments alongside venture firms, or participating in limited partner commitments to funds.

Where does the underlying wealth come from?

The endowment originates from the estate of Camille Dreyfus, a Swiss chemist who, with his brother Henry, commercialized cellulose acetate production and founded the Celanese Corporation. The fortune was built in the chemical and textile industries during the first half of the 20th century. Camille Dreyfus specifically dedicated the assets to the advancement of chemistry in honor of Henry, who died in 1944.

How is the Dreyfus Prize structured, and who has won it?

The biennial Dreyfus Prize in the Chemical Sciences features a $250,000 monetary award and a citation, focused on a rotating theme within chemistry. Past recipients include Robert Langer (MIT), Frances Arnold (Caltech), and Peidong Yang (UC Berkeley)—each recognized for foundational contributions. The 2024 cycle is dedicated to Environmental Chemistry. The prize is the largest of its kind focused exclusively on a single disciplinary theme in chemistry.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on endowments & foundations?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

More New York Endowment / Foundation profiles